These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15567349)

  • 1. A modeling approach to the impact of HIV mutations on the immune system.
    Vergu E; Mallet A; Golmard JL
    Comput Biol Med; 2005 Jan; 35(1):1-24. PubMed ID: 15567349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient.
    Stan GB; Belmudes F; Fonteneau R; Zeggwagh F; Lefebvre MA; Michelet C; Ernst D
    IET Syst Biol; 2008 Mar; 2(2):94-102. PubMed ID: 18397120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A viral load-based cellular automata approach to modeling HIV dynamics and drug treatment.
    Shi V; Tridane A; Kuang Y
    J Theor Biol; 2008 Jul; 253(1):24-35. PubMed ID: 18083195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the intra-host dynamics of HIV-1 infections.
    Stilianakis NI; Schenzle D
    Math Biosci; 2006 Jan; 199(1):1-25. PubMed ID: 16343556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic multidrug therapies for HIV: a control theoretic approach.
    Wein LM; Zenios SA; Nowak MA
    J Theor Biol; 1997 Mar; 185(1):15-29. PubMed ID: 9093552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects.
    Smith RJ; Wahl LM
    Bull Math Biol; 2005 Jul; 67(4):783-813. PubMed ID: 15893553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural variation in HIV infection: Monte Carlo estimates that include CD8 effector cells.
    Heffernan JM; Wahl LM
    J Theor Biol; 2006 Nov; 243(2):191-204. PubMed ID: 16876200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART.
    Jones LE; Perelson AS
    Bull Math Biol; 2005 Nov; 67(6):1227-51. PubMed ID: 16023709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A delay-differential equation model of HIV related cancer-immune system dynamics.
    Foryś U; Poleszczuk J
    Math Biosci Eng; 2011 Apr; 8(2):627-41. PubMed ID: 21631150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus dynamics: the effect of target cell limitation and immune responses on virus evolution.
    Regoes RR; Wodarz D; Nowak MA
    J Theor Biol; 1998 Apr; 191(4):451-62. PubMed ID: 9631576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oscillatory viral dynamics in a delayed HIV pathogenesis model.
    Wang Y; Zhou Y; Wu J; Heffernan J
    Math Biosci; 2009 Jun; 219(2):104-12. PubMed ID: 19327371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.
    de Mendoza C; Martín-Carbonero L; Gallego O; Corral A; González-Lahoz J; Soriano V
    J Med Virol; 2005 May; 76(1):1-6. PubMed ID: 15778973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the potential impact of a cytotoxic T-lymphocyte HIV vaccine: how often should you vaccinate and how strong should the vaccine be?
    Smith RJ; Schwartz EJ
    Math Biosci; 2008 Apr; 212(2):180-7. PubMed ID: 18359048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCM-1: a nonlinear dynamical computational model to simulate cellular changes in the T cell system; conceptional design and validation.
    Krueger GR; Brandt ME; Wang G; Buja LM
    Anticancer Res; 2003; 23(1A):123-35. PubMed ID: 12680203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential.
    Beq S; Delfraissy JF; Theze J
    Eur Cytokine Netw; 2004; 15(4):279-89. PubMed ID: 15627636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimisation and parallelisation strategies for Monte Carlo simulation of HIV infection.
    Hecquet D; Ruskin HJ; Crane M
    Comput Biol Med; 2007 May; 37(5):691-9. PubMed ID: 16901479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of immune escape in HIV infection.
    Wodarz D; Nowak MA
    Wien Klin Wochenschr; 1999 Jun; 111(11):419-27. PubMed ID: 10420492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune activation and inflammation in HIV-1 infection: causes and consequences.
    Appay V; Sauce D
    J Pathol; 2008 Jan; 214(2):231-41. PubMed ID: 18161758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.